State-of-the-Art Review: Data and Trust to Improve Care for Transgender and Gender-Diverse Patients.

IF 8.2 1区 医学 Q1 IMMUNOLOGY
Nicholas Van Sickels, Jennifer W H Wong, Evelyn Villacorta-Cari, Steph E Lee, Keisa Fallin-Bennett
{"title":"State-of-the-Art Review: Data and Trust to Improve Care for Transgender and Gender-Diverse Patients.","authors":"Nicholas Van Sickels, Jennifer W H Wong, Evelyn Villacorta-Cari, Steph E Lee, Keisa Fallin-Bennett","doi":"10.1093/cid/ciae480","DOIUrl":null,"url":null,"abstract":"<p><p>Healthcare for transgender and gender-diverse (TGD) patients is evolving. With 1.6 million people in the United States identifying as transgender, clinicians have significant opportunity to learn, build trust, and offer thoughtful preventive and therapeutic care. Gender-affirming care starts by using chosen names and pronouns and creating welcoming environments. Medical and surgical care for TGD persons is endorsed by multiple medical societies and is associated with reduced symptoms of dysphoria and improved quality of life. Barriers accessing this care include a lack of provider knowledge and availability, socioeconomic factors, discrimination, ongoing anti-LGBTQ+ legislation, and mistreatment from the medical system. Complications of gender-affirming surgical procedures are uncommon when performed by qualified and well-trained surgeons, though often patients must travel significant distances to attain surgical care, limiting postoperative follow-up. Complications of non-medical-grade procedures, such as fillers, are common and can present many years after the initial procedure. With respect to sexual wellness, social and biomedical interventions addressing disproportionate effects of human immunodeficiency virus and sexually transmitted infections on TGD people show promise in clinical trials. Further education for providers and patients, advocacy for affirming spaces and policies promoting evidence-based care, and building trust are crucial for holistic care of TGD patients.</p>","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":"80 2","pages":"e16-e30"},"PeriodicalIF":8.2000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cid/ciae480","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Healthcare for transgender and gender-diverse (TGD) patients is evolving. With 1.6 million people in the United States identifying as transgender, clinicians have significant opportunity to learn, build trust, and offer thoughtful preventive and therapeutic care. Gender-affirming care starts by using chosen names and pronouns and creating welcoming environments. Medical and surgical care for TGD persons is endorsed by multiple medical societies and is associated with reduced symptoms of dysphoria and improved quality of life. Barriers accessing this care include a lack of provider knowledge and availability, socioeconomic factors, discrimination, ongoing anti-LGBTQ+ legislation, and mistreatment from the medical system. Complications of gender-affirming surgical procedures are uncommon when performed by qualified and well-trained surgeons, though often patients must travel significant distances to attain surgical care, limiting postoperative follow-up. Complications of non-medical-grade procedures, such as fillers, are common and can present many years after the initial procedure. With respect to sexual wellness, social and biomedical interventions addressing disproportionate effects of human immunodeficiency virus and sexually transmitted infections on TGD people show promise in clinical trials. Further education for providers and patients, advocacy for affirming spaces and policies promoting evidence-based care, and building trust are crucial for holistic care of TGD patients.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Infectious Diseases
Clinical Infectious Diseases 医学-传染病学
CiteScore
25.00
自引率
2.50%
发文量
900
审稿时长
3 months
期刊介绍: Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信